Pulse Dose Erlotinib and Zuckerguss Improvement in EGFR-Mutant NSCLC

J Thorac Oncol. 2017 Dec;12(12):1857-1858. doi: 10.1016/j.jtho.2017.07.024. Epub 2017 Jul 31.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Carcinoma, Non-Small-Cell Lung / diagnostic imaging
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Erlotinib Hydrochloride / pharmacology
  • Erlotinib Hydrochloride / therapeutic use*
  • Female
  • Humans
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use*
  • Pulse Therapy, Drug / methods*

Substances

  • Protein Kinase Inhibitors
  • Erlotinib Hydrochloride